Home Top Movers Tenax Therapeutics, Inc. (TENX) Stock Undergo Minor Volatility Following Further Development of...

Tenax Therapeutics, Inc. (TENX) Stock Undergo Minor Volatility Following Further Development of its Pipeline Candidates

Tenax Therapeutics, Inc. (TENX) stock prices were down by a marginal 0.53% as of the market closing on May 25th, 2021, bringing the price per share down to USD$1.88 at the end of the trading day.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

R&D Expenses

Expenses incurred by research and development during the first quarter of the fiscal year 2021 came out to USD$22.4 million, significantly higher than the USD$1.3 million reported in the first quarter of 2020. The higher research and development costs over Q1 2021 are largely attributable to the recognition of roughly USD$21.8 million of in-process research and development related to the acquisition of PHPM in January of 2021.

5 Stocks Under $10 That Are Poised to Take Off

Investing in stocks under $10 could significantly increase the returns on your portfolio, especially if you pick the right stocks! Within this report you will find 5 top stocks that offer investors huge upside potential and the best bang for their buck.

Add them to your watchlist before they take off!

Get the Top 5 Stocks Now!

Sponsored

Read More

G7A Expenses and Net Loss

General and administrative expenses for the first quarter of 2021 were up from USD$1.3 million in Q1 2020 to USD$1.4 million. Net loss was down to USD$23.7 million, representing a net loss of USD$1.64 per share. This is comparable to the USD$2.7 million in net loss reported for the first quarter of 2020, representing a net loss of USD$0.38 per share.

Solid Liquidity Position

The company reported having cash, cash equivalents, and marketable securities in the amount of USD$4 million as of March 31st, 2021, compared to the USD$6.7 million reported as of December 31st, 2020. TENX anticipates its solid liquidity position being enough to cover the current operations through to the end of the third quarter of the fiscal year 2021.

Acquisition of PHPM

January 19th, 2021 saw TENX announce the acquisition of the privately-held clinical-stage biotech company PHPrecisionMed Inc. PHPM focusses on the development of imatinib for the treatment of pulmonary arterial hypertension (PAH). This acquisition of PHPM has immediately expanded TENX’s pipeline owing to the inclusion of a second de-risked Phase 3 ready candidate. This candidate has the potential to be the first disease-modifying treatment of pulmonary arterial hypertension.

Get the hottest stocks to trade every day before the market opens 100% ‎free. Click here now. 

Future Outlook for TENX

Armed with a solid liquidity position that will see the company through the next several months, TENX is poised to capitalize on its recent acquisition and facilitate further growth. Current and potential investors are hopeful that the company will continue to leverage the resources at its disposal to usher in significant and sustained increases in shareholder value.

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Must Read

Can-Fite BioPharma Inc. (CANF) stock soars during current market. Why so?

Can-Fite BioPharma Inc. (NASDAQ: CANF) stock gained by 4.42% in the current market trading session. Can-Fite BioPharma Ltd. is a medication research company in...

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Opgen Inc. (OPGN) stock surged during pre-market session. What’s driving it high?

Opgen Inc. (NASDAQ: OPGN) stock declined by 1.84% at the last close whereas the OPGN stock price gains by 22.07% in the pre-market trading...

Vista Gold Corp. (VGZ) stock soars during pre-market trading. Here’s what you should know

Vista Gold Corp. (NASDAQ: VGZ) stock gained by 17.65% in the pre-market trading session. Vista is a project developer with a gold rating. The...

Novan Inc. (NOVN) stock soars during pre-market trading. What’s driving it high?

Novan Inc. (NASDAQ: NOVN) stock gained by 62.39% at last close whereas the NOVN stock price surged by 0.82% in the pre-market trading session....

UXIN stock surges during current market. Here’s to know why?

Uxin Ltd. (NASDAQ: UXIN) stock gains by 14.67% at last check during current market trading. In China, Uxin Limited is a prominent online used...

Avenue Therapeutics Inc. (ATXI) stock plunged during pre-market trading. What’s behind this?

Avenue Therapeutics Inc. (NASDAQ: ATXI) stock declined by 28.27% at last close while the ATXI stock price falls during pre-market as well, by 8.94%....

Unique Fabricating Inc. (UFAB) stock gains during pre-market trading. Let’s figure out why?

Unique Fabricating Inc. (NASDAQ: UFAB) stock declined by 1.21% at the last close while the UFAB stock price tends to rise by 40.67% in...

Related News

Document Security System Inc. (DSS) stock plunged during after-hour session. Here’s to know the update

Document Security System Inc. (NASDAQ: DSS) stock declined by 6.76% at last close while the DSS stock price falls by 18.48% in the after-hours...

RAPT Therapeutics Inc. (RAPT) stock soars during current market trading. Stated below is the update

RAPT Therapeutics Inc. (NASDAQ: RAPT) stock gained by 85.46% in the current market trading. RAPT Therapeutics is a clinical-stage immunology-based pharmaceutical business focusing on...

Why Enochian Biosciences, Inc. (ENOB) stock Skyrocketed today?

Shares of the Enochian Biosciences, Inc. (ENOB) stock had skyrocketed today on June 14, 2021, following the announcement of FDA acceptance of Pre-IND request...

Why is Aptose Biosciences Inc. (APTO) stock gaining today?

Shares of the Aptose Biosciences Inc. (APTO) stock were gaining in the pre-market session today on June 14, 2021, despite no recent activity by...

Sorrento Therapeutics Inc. (SRNE) stock gained during after-hours. Here’s what you should know

Sorrento Therapeutics Inc. (NASDAQ: SRNE) stock surged by 1.6% at the last close while the SRNE stock price rises by 5.07% in the after-hours...

LEAVE A REPLY

Please enter your comment!
Please enter your name here

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

Get The Best Stocks To Trade Every Day!

Join now to get the NewsHeater.com pre-market morning brief 100% free

We do not sell or share your information with anyone.

Get Notified Of Insider Trades, Analyst Upgrades & Downgrades, Earnings Updates & Best Stocks To Trade Every Single Morning

100% free. stop anytime no spam